Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction

JACC: Cardiovascular Imaging

Volumn 4, Issue 6, 2011, Pages 610-618

  Matsumoto, Hidenari ^a   Matsuda, Tetsuya ^b   Miyamoto, Kenichi ^a   Shimada, Toshihiko ^a   Mikuri, Mikiko ^a   Hiraoka, Yuji ^a  

^a RAKUWAKAI OTOWA HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

acute myocardial infarction; area at risk; early contrast enhanced cardiac magnetic resonance; late contrast enhanced cardiac magnetic resonance; peri infarct zone

Indexed keywords

GADOLINIUM;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE REPERFUSION; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; CORONARY CIRCULATION; FEMALE; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958833181     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.03.015     Document Type: Article

References (27)

1. Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction. Current and emerging applications. J Am Coll Cardiol 2010;55:1-16.
2. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003;5: 613-5.
3. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105:224-9. (Pubitemid 34084323)
4. Wagner A, Mahrholdt H, Thomson L, et al. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol 2006;47:2027-33.
5. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002. (Pubitemid 29529292)
6. Saeed M, Bremerich J, Wendland MF, Wyttenbach R, Weinmann HJ, Higgins CB. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 1999;213:247-57. (Pubitemid 29470434)
7. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 2001;103:871-6. (Pubitemid 32163887)
8. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance imaging of 2-dayold reperfused canine infarct. Circulation 1995;92:1902-10.
9. Schaefer S, Malloy CR, Katz J, et al. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol 1988;12:1064-72.
10. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-42. (Pubitemid 33126660)
11. Ibrahim T , Nekolla SG, Hörnke M, et al. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 2005;45:544-52. (Pubitemid 40222249)
12. Aletras AH, Tilak GS, Natanzon A, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113:1865-70. (Pubitemid 43739398)
13. Tilak GS, Hsu L-Y, Hoyt RF, Arai AE, Aletras AH. In vivo T2 weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol 2008; 43:7-15.
14. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1581-7. (Pubitemid 351508364)
15. Cerqueira MD, Weissman NJ, Dilsizian V, et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105: 539-42.
16. Judd RM, Kim RJ. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2002;106:e6.
17. Dauber IM, VanBenthuysen KM, Mc-Murtry IF, et al. Functional coronary artery microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res 1990;66:986-98. (Pubitemid 20126430)
18. Zhao M, Zhang H, Robinson TF, Factor SM, Sonnenblick EH, Eng C. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ("stunned") but viable myocardium. J Am Coll Cardiol 1987;10:1322-34. (Pubitemid 18004686)
19. Arheden H, Saeed M, Higgins CB, et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 2000;215:520-8. (Pubitemid 30237855)
20. Klein C, Schmal TR, Nekolla SG, Schnackenburg B, Fleck E, Nagel E. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2007;9:653-8. (Pubitemid 46956899)
21. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36: 1985-91.
22. Reimer KA, Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633-44.
23. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989; 80:1277-86. (Pubitemid 19282516)
24. Bekkers SC, Backes WH, Kim RJ, et al. Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. Eur Radiol 2009;19:2904-12.
25. Nijveldt R, Hofman MB, Hirsch A, et al. Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study. Radiology 2009;250: 363-70.
26. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med 2007;57: 891-7. (Pubitemid 46709409)
27. Keegan J, Gatehouse PD, Prasad SK, Firmin DN. Improved turbo spin echo imaging of the heart with motion-tracking. J Magn Reson Imaging 2006;24:563-70. (Pubitemid 44320558)